Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas

Acta Neuropathologica

Volumn 91, Issue 3, 1996, Pages 221-225

  Ono, Yasuhiro ^a   Ueki, Keisuke ^a   Joseph, Jeffrey T ^a,b,c   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

CDKN2; Hemangiopericytoma; Meningioma; p16; p53

Indexed keywords

ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DURA MATER; EXON; GENE DELETION; GENE MUTATION; HEMANGIOPERICYTOMA; HISTOGENESIS; HUMAN; HUMAN TISSUE; MENINGIOMA; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; REGULATOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM;

GENE DELETION; GENES, TUMOR SUPPRESSOR; HEMANGIOPERICYTOMA; HOMOZYGOTE; HUMANS; MENINGEAL NEOPLASMS;

EID: 0030034613     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050419     Document Type: Article

References (35)

1. Burger PC, Scheithauer BW (1994) Tumors of the central nervous system. Armed Forces Institute of Pathology, Washington, DC
2. Burger PC, Scheithauer BW, Vogel FS (1991) Surgical pathology of the nervous system and its coverings, 3rd edn. Churchill Livingstone, New York
3. Cairns P, Tokino K, Eby Y, Sidransky D (1994) Homozygous deletions of 9p21 primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54: 1422-1424
4. Caldas C, Hahn SA, Costa LT da, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomas. Nature Genet 8: 27-32
5. Chaubal A, Paetau A, Zoltick P, Miettinen M (1994) CD34 immunoreactivity in nervous system tumors. Acta Neuropathol 88: 454-458
6. D'Amore ESG, Manivel JC, Sung JH (1990) Soft-tissue and meningeal hemangiopericytomas: an immunohistochemical and ultrastructural study. Hum Pathol 21: 414-423
7. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
8. Forus A, Florenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O (1993) Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ 4: 1065-1070
9. Forus A, Florenes VA, Maelandsmo CM, Fodstad O, Myklebost O (1994) The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Cancer Gen Cytosenet 78: 165-171
10. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etioloay and molecular pathogenesis. Cancer Res 54: 4855-4878
11. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
12. Horten BC, Urich H, Rubinstein LJ, Montague SR (1977) The angioblastic meningioma: a reappraisal of a nosological problem. Light, electron microscopic, tissue, and organ culture observations. J Neurol Sci 31: 387-410
13. Jen J, Harper W, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B (1994) Deletion of p16 and p15 in brain tumors. Cancer Res 54: 6353-6358
14. Joseph JT, Lisle DK, Jacoby LB, Paulus W, Barone R, Cohen ML, Roggendorf WH, Bruner JM, Gusella JF, Louis DN (1995) NF2 gene analysis distinguishes hemangiopericytoma from meningioma. Am J Pathol 147: 1450-1455
15. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
16. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. Springer, Berlin Heidelberg New York
17. Koh J, Enders GH, Dynlacht BD, Harlow E (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510
18. Louis DN (1994) The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 53: 11-21
19. Louis DN, Rubio M-P, Correa K, Gusella JF, Deimling A von (1993) Molecular genetic alterations in pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 52: 507-515
20. Louis DN, Deimlina A von, Chung RY, Rubio M-P, Whaley JH, Ohgaki H, Eibl R, Wiestler OD, Thor AD, Seizinger BR (1993) Comparative study of p53 gene and protein alterations in human astrocytomas. J Neuropathol Exp Neurol 52: 31-38
21. Louis DN, Ramesh V, Gusella JF (1995) Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5: 163-172
22. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p 16. Nature 375: 503-506
23. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92: 6289-6293
24. Mori T, Miura K, Aoki T, Nishihira T, Mon S, Nakamura Y (1994) Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397
25. Muller J, Mealey JJ (1971) The use of tissue culture in differentiation between angioblastic meningioma and hemangiopericytoma. J Neurosurg 34: 341-348
26. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756
27. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202-6205
28. Renshaw AA, Paulus W, Joseph JT (1995) CD34 and EMA distinguish durai hemangiopericytoma and meningioma. J Appl Histochem 3: 108-114
29. Rubio M-P, Deimling A von, Yandell DW, Wiestler OD, Gusella JF, Louis DN (1993) Accumulation of wild-type p53 protein in human astrocytomas. Cancer Res 53: 3465-3467
30. Russell DS, Rubinstein LJ (1989) Pathology of tumours of the nervous system, 5th edn. Williams & Wilkins, Baltimore
31. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707
32. Theaker JM, Gatter KC, Esiri MM, Fleming KA (1986) Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study. J Clin Pathol 39: 435-439
33. Ueki K, Rubio M-P, Ramesh V, Correa KM, Rutter JL, Deimling A von, Buckler AJ, Gusella JF, Louis DN (1994) MTS1/ CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Molec Genet 3: 1841-1845
34. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN (in press) CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res
35. Walker DO, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M (1995) Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55: 20-23